Claire L. Ambery
GSK Stockley Park
United Kingdom
United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
A Combined Model-Based Meta-Analysis of Aggregated and Individual FEV1 Data From Randomized COPD Trials.
Journal: CPT: pharmacometrics & systems pharmacology
Published: October 23, 2024
Joint longitudinal model-based meta-analysis of FEV1 and exacerbation rate in randomized COPD trials.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: January 11, 2023
General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children.
Journal: British journal of clinical pharmacology
Published: October 21, 2021
Improved Confidence in a Confirmatory Stage by Application of Item-Based Pharmacometrics Model: Illustration with a Phase III Active Comparator-Controlled Trial in COPD Patients.
Journal: Pharmaceutical research
Published: September 23, 2021
Improved Decision-Making Confidence Using Item-Based Pharmacometric Model: Illustration with a Phase II Placebo-Controlled Trial.
Journal: The AAPS journal
Published: January 09, 2021
Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK.
Journal: Pharmaceutical research
Published: February 28, 2020
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
Journal: Respiratory research
Published: January 15, 2020
A Novel Method for Analysing Frequent Observations from Questionnaires in Order to Model Patient-Reported Outcomes: Application to EXACT® Daily Diary Data from COPD Patients.
Journal: The AAPS journal
Published: November 20, 2018
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Danirixin Hydrobromide Tablets in Japanese Healthy Elderly Participants.
Journal: Clinical pharmacology in drug development
Published: November 01, 2018
Time-to-Event Modeling of Left- or Right-Censored Toxicity Data in Nonclinical Drug Toxicology.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: May 23, 2018
Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD.
Journal: The European respiratory journal
Published: January 26, 2018
Open-Label, Crossover Study to Determine the Pharmacokinetics of Fluticasone Furoate and Batefenterol When Administered Alone, in Combination, or Concurrently.
Journal: Clinical pharmacology in drug development
Published: November 15, 2017
Last Updated: 09/26/2026